 Knowledge Wharton Today | Patent Controversy Resumes as Indian Supreme Court Rejects Novartis' Glivec ... Knowledge Wharton Today ... wars that have been fought in India over the past few years. By and large, multinationals have been losing out — for example, Hyderabad-based firm Natco Pharma was granted a compulsory license for Bayer's liver and kidney anti-cancer drug Nexavar. Why the rejection of Novartis patent plea is a huge victory for India India court ruling could deprive developing nations of patented drugs Patent problems |
